Document:

<PAGE>

                                                                   Exhibit 10.20

                         MANUFACTURERS' SERVICES LIMITED
                     NON-EMPLOYEE DIRECTOR STOCK OPTION PLAN

1. NAME AND PURPOSE. This plan shall be called the Manufacturers' Services
Limited Non-Employee Director Stock Option Plan (the "Plan"). The Plan is
intended to encourage stock ownership by Non-Employee Directors (as defined
below) of Manufacturers' Services Limited, a Delaware corporation (the
"Company"), to provide such directors with an additional incentive to manage the
Company effectively and to contribute to its success, and to provide a form of
compensation which will attract and retain highly qualified individuals as
members of the Board of Directors of the Company.

2. EFFECTIVE DATE AND TERM OF THE PLAN. The Plan shall become effective on the
date of the consummation of the initial public offering of the Company's common
stock, par value $.001 per share (the "Effective Date"). Options may not be
granted under the Plan after the tenth (l0th) anniversary of the Effective Date
(the "Term"); provided, however, that all options outstanding as of that date
shall remain or become exercisable pursuant to their terms and the terms of the
Plan.

3. ADMINISTRATION. The Plan shall initially be administered by the Board of
Directors of the Company (the "Board"). The Board shall delegate the
administration of the Plan to a committee of Board (the "Committee") in the
event such a committee is established by the Board for such purpose and that
committee is composed solely of two or more "Non-Employee Directors" (as such
term is defined under Rule 16b-3 under the Securities Exchange Act of 1934, as
amended (the "Exchange Act")). Each member of the Committee shall be eligible to
participate in the Plan. References herein to the Committee shall be deemed to
refer to the Board in the event that the administration of the Plan has not been
delegated to the Committee. The Committee may, from time to time, establish such
regulations, provisions and procedures, within the terms of the Plan, as in the
opinion of its members may be advisable in the administration of the Plan. A
majority of the Committee shall constitute a quorum, and the acts of a majority
of a quorum at any meeting, or acts reduced to or approved in writing by a
majority of the members of the Committee, shall be the valid acts of the
Committee. The interpretation and construction by the Committee of any
provisions of the Plan or of any option granted pursuant to the Plan shall be
final and binding upon the Company and any optionee. No member of the Board of
Directors of the Company or the Committee shall be liable for any action or
determination made in good faith with respect to the Plan or any option granted
pursuant thereto.

4. STOCK AVAILABLE FOR OPTIONS. Subject to the adjustments as provided in
Subsection 7(f), the aggregate number of shares of common stock, par value $.001
per share, of the Company (the "Common Stock") reserved for purposes of the Plan
shall be 225,000 shares of authorized and unissued shares or issued shares
reacquired by the Company (the "Shares"). Determinations as to the number of
Shares that remain available for issuance under the Plan

                                        1

<PAGE>

shall be made in accordance with such rules and procedures as the Committee
shall determine from time to time. If any outstanding option under the Plan
expires or is terminated for any reason before the end of the Term of the Plan,
the Shares allocable to the unexercised portion of such option shall become
available for the grant of other options under the Plan. No shares delivered to
the Company in full or partial payment upon exercise of an option pursuant to
Subsection 7(c) or in full or partial payment of any withholding tax liability
permitted under Section 10 shall become available for the grant of other options
under the Plan.

5. PARTICIPATION. Subject to the limitations contained in this Section 5, any
director of the Company who is not a contractual nor common law employee of the
Company or any of its subsidiaries (a "Non-Employee Director") will be eligible
to be granted options to purchase shares of the issued or issuable Common Stock
in accordance and consistent with the terms and conditions of the Plan. An
optionee may hold more than one option, but only on the terms and subject to the
restrictions hereafter set forth. Except as provided herein, terms and
conditions of options granted to a director at any given time need not be the
same for any other grant of options.

6.       OPTION GRANTS.

         (a) DISCRETIONARY GRANTS. In addition to the automatic option grants
provided for in Subsections (b) and (c) hereof, the Committee shall be
authorized to determine from time to time the directors (among the Non-Employee
Directors) to be granted options, the number of shares of Common Stock subject
to such options, and the terms and conditions of the options to be granted. All
options granted under this Subsection (a) must be approved by either the Board
or the Committee prior to such grant.

         (b) INITIAL GRANTS. Each Non-Employee Director who was in office prior
to the Effective Date and remains in office after the Effective Date, shall
automatically be granted options to purchase 20,000 shares of Common Stock
unless such Non-Employee Director had previously received a such a grant prior
to the Effective Date. Any individual elected to the Board as a Non-Employee
Director after the Effective Date shall automatically be granted options to
purchase 20,000 shares of Common Stock (as adjusted pursuant to Section 8
hereof) upon initial election to such position.

         (c) ANNUAL GRANTS. Each Non-Employee Director shall automatically be
entitled to be granted options to purchase 5,000 shares of Common Stock (as
adjusted pursuant to Section 8 hereof) on each anniversary of such Non-Employee
Director's election to the Board of Directors. Such options will be granted to
each Non-Employee Director on the date of the Company's Annual Meeting of
Stockholders (or such other date as determined by the Board in the event that an
Annual Meeting of Stockholders is not held by the Company).

         (d) NON-STATUTORY STOCK OPTIONS. All options granted under the Plan
shall be non-statutory options not intended to qualify under Section 422 of the
Internal Revenue Code of

                                        2

<PAGE>

1986, as amended (the "Code"). Each option granted under the Plan shall provide
that such option will not be treated as an "incentive stock option," as that
term is defined in Section 422(b) of the Code.

7. TERMS AND CONDITIONS OF OPTIONS OF THE PLAN. Options granted under this Plan
shall be evidenced by agreements in such form as the Committee shall from time
to time approve, which agreements shall comply with and be subject to the
following conditions:

         (a) TERM OF OPTIONS. The term of each option shall be for a period of
not greater than ten (10) years from the date of grant of the option.

         (b) OPTION PRICE. The exercise price of each option shall be equal to
one hundred percent (100%) of the Fair Market Value of the shares of Common
Stock on the date of the grant of the option. If the shares are traded in the
over-the-counter market, the Fair Market Value per share shall be the closing
price on the national market list as quoted in the National Association of
Securities Dealers Automated Quotation System ("Nasdaq") on the day the option
is granted or if no sale of shares is reflected in Nasdaq on that day, on the
next preceding day on which there was a sale of shares reflected in Nasdaq. If
the shares are not traded in the over-the-counter market but are listed upon an
established stock exchange or exchanges, such Fair Market Value shall be deemed
to be the closing price of the shares on such stock exchange or exchanges on the
day the option is granted or if no sale of the shares shall have been made on
any stock exchange on that day, on the next preceding day on which there was a
sale of the shares.

         (c) MEDIUM OF PAYMENT. The option price shall be payable to the Company
either (i) in United States dollars in cash or by check, bank draft, or money
order payable to the order of the Company or (ii) if permitted by the Board,
through the delivery of shares of the Common Stock with a Fair Market Value on
the date of the exercise equal to the option price, provided such shares are
utilized as payment to acquire at least 100 shares of Common Stock, or (iii) by
a combination of (i) and (ii) above. Fair Market Value will be determined in the
manner specified in Subsection 7(b) except as to the date of determination.

         (d) EXERCISE OF OPTIONS. Except as provided herein, the Committee shall
have the authority to determine, at the time of grant of each option pursuant to
Subsection 6(a), the times at which an option may be exercised and any
conditions precedent to the exercise of an option. Except as provided herein,
options granted pursuant to Subsection 6(b) and Subsection 6(c) shall become
exercisable in three equal installments beginning on the first anniversary of
the date of grant and continuing on each anniversary thereafter until all such
options are exercisable. An option shall be exercisable upon written notice to
the Chief Financial Officer of the Company, as to any or all shares covered by
the option, until its termination or expiration in accordance with its terms or
the provisions of the Plan. Notwithstanding the foregoing, an option shall not
at any time be exercisable with respect to less than 100 shares unless the
remaining shares covered by an option are less than 100 shares. The purchase
price

                                        3

<PAGE>

of the shares purchased pursuant to an option shall be paid in full upon
delivery to the optionee of certificates for such shares. Exercise by an
optionee's heir, personal representative or permitted transferee shall be
accompanied by evidence of his or her authority to act, in a form reasonably
satisfactory to the Company.

         (e)      TERMINATION OF SERVICE AS DIRECTOR.

                  (i) TERMINATION OF SERVICE FOR ANY REASON OTHER THAN DEATH. In
         the event an optionee shall cease to serve the Company as a director
         for any reason other than such optionee's death or Permanent
         Disability, each option held by such optionee shall, to the extent
         rights to purchase shares under the option have been accrued at the
         time such optionee ceases to serve as a director, remain exercisable,
         in whole or in part, by the optionee, subject to prior expiration
         according to its terms and other limitations imposed by the Plan, for a
         period of one (1) year following the optionee's cessation of service as
         a director of the Company. If the optionee dies after such cessation of
         service, the optionee's options shall be exercisable in accordance with
         Subsection 6(e)(ii) hereof.

                  (ii) TERMINATION OF SERVICE FOR DEATH OR PERMANENT DISABILITY.
         If an optionee ceases to be a director by reason of death or Permanent
         Disability, each option held by such optionee shall immediately become
         exercisable and shall remain exercisable, in whole or in part, by (in
         the case of Permanent Disability) the optionee or (in the case of
         death) the personal representative of the optionee's estate or by any
         person or persons who have acquired the option directly from the
         optionee during the shorter of the following periods: (A) the term of
         the option, or (B) a period of two (2) years from the death or
         Permanent Disability of such optionee. If an optionee dies or a
         Permanent Disability occurs during the extended exercise period
         following cessation of service specified in Subsection 6(e)(i) above,
         such option may be exercised any time within the longer of such
         extended period or one (1) year after death or Permanent Disability,
         subject to the prior expiration of the term of the option. For purposes
         of this Subsection 6(e)(ii), "PERMANENT DISABILITY" shall mean a
         determination by the Social Security Administration or any similar
         successor agency that an optionee is "permanently disabled," and the
         date on which a Permanent Disability is deemed to have occurred shall
         be the date on which such determination by such agency shall have been
         made.

         (f) ADJUSTMENT IN SHARES COVERED BY OPTION. The number of shares
covered by each outstanding option, and the purchase price per share thereof,
shall be proportionately adjusted for any increase or decrease in the number of
issued and outstanding shares resulting from a split in or combination of shares
or the payment of a stock dividend on the shares or any other increase or
decrease in the number of such shares effected without receipt of consideration
by the Company. If the Company shall be the surviving corporation in any merger
or consolidation or if the Company is merged into a wholly-owned subsidiary
solely for

                                        4

<PAGE>

purposes of changing the Company's state of incorporation, each outstanding
option shall pertain to and apply to the securities to which a holder of the
number of shares subject to the option would have been entitled to receive in
such transaction. In the event of a Change in Control, only if provided in the
option agreement, any option awarded under this Plan to the extent not
previously exercisable shall immediately become fully exercisable. The Committee
in its sole discretion may direct the Company to cash out all outstanding
options on the basis of the Change in Control Price as of the date a Change in
Control occurs or such other date as the Committee may determine prior to the
Change in Control. For purposes of this Plan, a "CHANGE IN CONTROL" means the
occurrence of any of the following: (A) when any "person" as defined in Section
3(a)(9) of the Exchange Act and as used in Sections 13(d) and 14(d) thereof,
including a "group" as defined in Section 13(d) of the Exchange Act but
excluding the Company and any subsidiary, any of the Company's existing
stockholders prior to the Effective Date and any employee benefit plan sponsored
or maintained by the Company or any subsidiary (including any trustee of such
plan acting as trustee), directly or indirectly, becomes the "beneficial owner"
(as defined in Rule 13d-3 under the Exchange Act, as amended from time to time),
after the Effective Date, of securities of the Company representing twenty
percent (20%) or more of the combined voting power of the Company's then
outstanding securities; (B) when, during any period of 24 consecutive months
during the existence of the Plan, the individuals who, at the beginning of such
period, constitute the Board of Directors of the Company (the "INCUMBENT
DIRECTORS") cease for any reason other than death to constitute at least a
majority thereof; provided, however, that a director who was not a director at
the beginning of such 24-month period shall be deemed to have satisfied such
24-month requirement (and be an Incumbent Director) if such director was elected
by, or on the recommendation of or with the approval of, at least two-thirds of
the directors who then qualified as Incumbent Directors either actually (because
they were directors at the beginning of such 24 month period) or by prior
operation of this provision; or (C) the approval by the stockholders of the
Company of a transaction involving the acquisition of the Company by an entity
other than the Company or a subsidiary through purchase of assets, by merger, or
otherwise. For purposes of this Plan, "CHANGE IN CONTROL PRICE" means the
highest price per share of Common Stock paid in any transaction reported on the
New York Stock Exchange or paid or offered in any bona fide transaction related
to a Change in Control at any time during the 60-day period immediately
preceding the occurrence of the Change in Control, in each case as determined by
the Committee. In the event of a change in the shares as presently constituted,
which is limited to a change of all of its authorized shares with par value into
the same number of shares with a different par value or without par value, the
shares resulting from any such change shall be deemed to be the Shares within
the meaning of the Plan. To the extent that the foregoing adjustments relate to
stock or securities of the Company, such adjustments shall be made by the Board,
whose determination in that respect shall be final, binding and conclusive. Any
such adjustment may provide for the elimination of any fractional share which
might otherwise become subject to an option. Except as expressly provided in
this Subsection 7(f), the optionee shall have no rights by reason of any split
or combination of shares of stock of any class or the payment of any stock
dividend or any other increase or decrease in the number of shares of stock of
any class or by reason of any dissolution,

                                       5
<PAGE>

liquidation, merger, or consolidation or spinoff of assets or stock of another
corporation, and any issue by the Company of shares of stock of any class, or
securities convertible into shares of stock of any class, shall not affect, and
no adjustment by reason thereof shall be made with respect to, the number or
price of shares of stock subject to the option. The grant of an option pursuant
to the Plan shall not affect in any way the right or power of the Company to
make adjustments, reclassifications, reorganizations, or changes of its capital
or business structure, or to merge or to consolidate or to dissolve, liquidate
or sell, or transfer all or any part of its business or assets.

         (g) RIGHTS OF A STOCKHOLDER. An optionee shall have no rights as a
stockholder with respect to any shares covered by his or her option until the
date on which the optionee becomes the holder of record of such shares. No
adjustment shall be made for dividends, distributions, or other rights for which
the record date is prior to the date on which he or she shall have become the
holder of record thereof, except as provided in Subsection 7(f).

         (h) POSTPONEMENT OF DELIVERY OF SHARES AND REPRESENTATIONS. The
Company, in its discretion, may postpone the issuance and/or delivery of shares
upon any exercise of an option until completion of the registration or other
qualification of such shares under any state and/or federal law, rule or
regulation as the Company may consider appropriate, and may require any person
exercising an option to make such representations, including a representation
that it is the optionee's intention to acquire shares for investment and not
with a view to distribution thereof, and furnish such information as it may
consider appropriate in connection with the issuance or delivery of the shares
in compliance with applicable laws, rules, and regulations. In such event no
shares shall be issued to such holder unless and until the Company is satisfied
with the accuracy of any such representations.

         (i) TRANSFERABILITY. If provided in the option agreement, the options
granted pursuant to the Plan may be transferable by a Non-Employee Director. The
Committee shall have the sole discretion to determine to what extent, if any,
the options granted pursuant to the Plan are transferable by a Non-Employee
Director.

         (j) OTHER PROVISIONS. The option agreements authorized under the Plan
shall contain such other provisions, including, without limitation, restrictions
upon the exercise of the option, as the Committee shall deem advisable.

8. ADJUSTMENTS IN SHARES AVAILABLE FOR OPTIONS. The adjustments in number and
kind of shares and the substitution of shares, affecting outstanding options in
accordance with Subsection 7(f) hereof, shall also apply to the number and kind
of shares issuable upon the exercise of options to be granted pursuant to
Section 6 and the number and kind of shares reserved for issuance pursuant to
the Plan, but not yet covered by options.

9. AMENDMENT OF THE PLAN. The Board, insofar as permitted by law, shall have the
right from time to time, with respect to any shares at the time not subject to
options, to suspend or

                                       6
<PAGE>

discontinue the Plan or revise or amend it in any respect whatsoever. So long as
the Common Stock is eligible for trading on the New York Stock Exchange, the
Board shall obtain stockholder approval for those revisions or amendments of the
Plan required to be so approved pursuant to the rules of the New York Stock
Exchange. If the Plan is amended so that the exemption provided by Rule 16b-3 as
a result of the Plan being approved by the stockholders of the Company is no
longer available for options granted under Subsections 6(b) or 6(c) hereof, all
options subsequently granted thereunder must be approved by either the Board or
the Committee prior to such grant.

10. WITHHOLDING OF TAXES. The Company shall have the right to deduct from any
payment to be made pursuant to this Plan, or to otherwise require, prior to the
issuance or delivery of any shares of Common Stock, payment by the optionee of
any federal, state, or local taxes required by law to be withheld. Unless
otherwise prohibited by the Committee, an optionee may satisfy any such
withholding tax obligation by any of the following means or by a combination of
such means: (a) tendering a cash payment; (b) authorizing the Company to
withhold from the shares otherwise issuable to the optionee a number of shares
having a Fair Market Value as of the "Tax Date," less than or equal to the
amount of withholding tax obligation; or (c) delivering to the Company
unencumbered shares owned by the optionee having a Fair Market Value, as of the
Tax Date, less than or equal to the amount of the withholding tax obligation.
The "TAX DATE" shall be the date that the amount of tax to be withheld is
determined. Fair Market Value shall be determined in the manner specified in
Subsection 7(b), except as to the date of determination. An optionee's election
to pay the withholding tax obligation by either of (b) or (c) above shall be
irrevocable, may be disapproved by the Committee, and must be made either six
(6) months prior to the Tax Date or during the period beginning on the third
business day following the date of release of the Company's quarterly or annual
summary statement of sales and earnings and ending on the twelfth business day
following such date.

11. RIGHT OF BOARD OF DIRECTORS OR STOCKHOLDERS TO TERMINATE DIRECTOR'S SERVICE.
Nothing in this Plan or in the grant of any option hereunder shall in any way
limit or affect the right of the Board of Directors or the stockholders of the
Company to remove any director or otherwise terminate his or her service as a
director, pursuant to the law, the Restated Certificate of Incorporation, or
Amended and Restated By-laws of the Company.

12. APPLICATION OF FUNDS. The proceeds received by the Company from the sale of
stock pursuant to options will be used for general corporate purposes.

13. NO OBLIGATION TO EXERCISE OPTION. The granting of an option shall impose no
obligation on the optionee to exercise such option.

14. CONSTRUCTION. This Plan shall be construed under the laws of the State of
Delaware.

                                       7<PAGE>

                                                                   EXHIBIT 10.11

   CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
                EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS.

                                     COREPORT-TM- LICENSE AND SERVICES AGREEMENT
                                                              QUICKSTART PACKAGE

[LOGO]

260 Franklin Street
Suite 1890
Boston, MA  02110
617-204-3300
617-204-3333 (fax)

<TABLE>

<S>               <C>
|X| CLIENT
    INFORMATION:  ABN AMRO INFORMATION TECHNOLOGY SERVICES CO.
                  --------------------------------------------------------------     -----------------------------------------
                  Client Name                                                        Billing Organization

                  200 West Monroe Street. E-Commerce Solutions Dep., Suite 2045
                  --------------------------------------------------------------     -----------------------------------------
                  Installation Address                                               Billing Address

                  Chicago IL 60606
                  --------------------------------------------------------------     -----------------------------------------
                  City, State, Zip                                                   City, State, Zip

                  Kristine Nofzinger (312) 904-1386
                  --------------------------------------------------------------     -----------------------------------------
                  Contact Name and Telephone                                         Attention

</TABLE>

|X| PRODUCT LICENSED:  COREPORT 2.1 (COREPORT 2.1 BROWSER CLIENT, COREPORT 2.1
                       SERVER ENGINE, CORETOOLS API, CORELINKS STANDARD
                       INTERFACES, AND AUTONOMY KNOWLEDGE MANAGEMENT, INCLUDING
                       QUERY/INDEX, USER AGENT, IMPORT, AUTO-SUGGEST AND
                       CATEGORIZER)

|X| LICENSE FEE:  [**]

|X| NUMBER OF AUTHORIZED LICENSES (MACHINES):  50 USERS

|X| PROFESSIONAL SERVICES:  FIVE (5) DAYS INSTALLATION/CONFIGURATION SUPPORT,
                            SEE ATTACHMENT A

|X| PROFESSIONAL SERVICES FEE:  [**]

|X| TRAINING:  ONE (1) DAY ON-SITE TRAINING

|X| ANNUAL SUPPORT FEE 18%:  [**]

|X| SPECIAL TERMS:  THE PILOT FEE WILL SERVE AS A CREDIT AGAINST FUTURE
                    LICENSE FEES.

This License and Services Agreement (the "Agreement") constitutes the entire
agreement between the parties and supersedes all prior agreements and
understandings, whether oral or written. If this Agreement conflicts with the
terms of a Client purchase order or any other writing, the terms of this
Agreement shall govern. By signing below, each party accepts and agrees to be
bound by the terms of this Agreement. It is understood that each party may
consider any fully signed reproduction of this Agreement to be a binding
original, if the reproduction is made by reliable commercial means (e.g.
photocopy, facsimile, e-mail). The Agreement shall not be binding upon
Corechange until reviewed and signed by either its President or Vice President
of Finance and Administration.

Corechange, Inc.                    ABN AMRO Information Technology Services Co.

/s/ Angiras Koorapaty               /s/ Louis F. Rosenthal
--------------------------------    --------------------------------------------
VP Finance and Administration       Louis F. Rosenthal
--------------------------------    --------------------------------------------
Date:  5/4/2000                     Date:  5/9/2000
--------------------------------    --------------------------------------------

                                       1
<PAGE>

                                     COREPORT-TM- LICENSE AND SERVICES AGREEMENT
                                                              QUICKSTART PACKAGE

                              TERMS AND CONDITIONS

1.0 LICENSE

1.1 GRANT.

Corechange grants Client, a nonexclusive, nontransferable LICENSE to use the
software programs known as Coreport (in object code format only), associated
documentation, and the software programs and documentation provided as a result
of the professional services ("Deliverables") (collectively, the "Licensed
Materials") in accordance with the terms and conditions of this Agreement. The
Licensed Materials are not being sold, rather all rights, title, and interest in
and to the Licensed Materials is retained by Corechange.

1.2 AUTHORIZED ACTIVITIES.

Client may: (a) install the software programs only on the authorized computer
systems(s) and locations, as defined by this Agreement, within the United States
and Canada; (b) use the Licensed Materials exclusively for Client's own internal
business use and benefit (including for the benefit of all majority owned
subsidiaries); and (c) make no more than one copy of the Licensed Materials only
for archival and back up purposes, provided that Client properly reproduces
copyright and other legal notices and restrictive legends of ownership on each
copy or partial copy. Client agrees to maintain records of all copies.

1.3 PROHIBITED ACTIVITIES.

Client may not: (a) reverse assemble, reverse compile, disassemble or otherwise
attempt to access the source code of the software programs without the prior
written approval of Corechange, unless such access is required by applicable
law, in which case Corechange may, in its discretion, perform such work at its
consulting rate, or allow Client to access the source code but only for the
limited, required purpose; or (b) sell, assign, sublicense, rent, lease, lend or
otherwise dispose of the Licensed Materials or transfer this license to any
other person, system or entity, including, without restriction, other Client
locations, service providers or facilities managers, except that Client may
assign without consent to a parent or wholly owned subsidiary by providing prior
written notice to Corechange.

2.0  SCOPE OF USE AND USE VERIFICATION

The front page of this Agreement specifies the Licensed Materials that are being
licensed and also defines the maximum installation and usage permitted under
this Agreement. Client may, at any time, increase the defined usage by providing
Corechange with prior written notice of the change. Additional license charges
as well as adjustments to the fees for Corechange Support may be incurred as a
result of this usage change. Corechange may reasonably request, at any time,
configuration documentation to verify the actual usage of the Licensed
Materials. Corechange may request from Client, but no more than twice annually,
and Client agrees to provide Corechange, a signed statement verifying the number
of user accounts administered by the Licensed Materials.

3.0 SERVICES

Corechange, its employees. agents and/or contractors shall provide the
professional services stated in Attachment A to this Agreement. Corechange
agrees to perform the services with care, skill and diligence in accordance with
applicable professional standards. Client agrees to fully cooperate with
Corechange and provide all assistance reasonably necessary for Corechange to
provide the required services. In the event that Corechange experiences delays
resulting from Client's failure to provide the necessary assistance including,
without limitation, the proper desktop and application operating environments
and personnel, Corechange may be required to bill Client an additional per diem
charge at its standard consulting rate.

4.0 PROPRIETARY INFORMATION

Both Corechange and Client may make available to the other confidential and
proprietary materials and information ("Proprietary Information"). All material
and information provided by one party to the other relating to its business,
policies, procedures, customs, forms, customers and strategies and identified in
writing as "confidential" or "proprietary" shall be considered to be Proprietary
Information. The Licensed Materials shall be deemed Proprietary Information
whether or not identified in writing as such. Proprietary Information does not
include information that: (i) is already, or otherwise becomes, generally known
by third parties as a result of no act or omission of the receiving party; (ii)
subsequent to disclosure hereunder is lawfully received from a third party
having the right to disseminate the information without restriction on
disclosure; (iii) is generally furnished to others by the disclosing party
without restriction on disclosure; (iv) was already known by the receiving party
prior to receiving them from the disclosing party and were not received from a
third party in breach of that third party's obligations of confidentiality; or
(v) is independently developed by the receiving party without the use of
Proprietary Information of the disclosing party. Each party shall maintain the
confidentiality of the other party's Proprietary Information and will not use or
disclose such Proprietary Information without the written consent of the other
party. Notwithstanding the foregoing, a party may disclose the Proprietary
Information of the other to its agents and other third parties on a need-to-know
basis, provided that such parties are under a similar obligation to maintain the
confidentiality of the Proprietary Information. Further, the parties may
disclose the other's Proprietary Information in a judicial or quasi-judicial
proceeding when required to do so by law when responding to a subpoena,
deposition notice or similar judicial or governmental demand; in such
situations, however, the party being requested to disclose the other's
Proprietary Information shall endeavor to provide notice to the other party
whereby the other party may intervene in the proceeding, if it wishes, and
endeavor to prevent such disclosure. Additionally, the parties may disclose the
other's Proprietary Information to their various regulatory agencies if
required, provided they take reasonable steps to limit further disclosure.
Notwithstanding any contrary provision of this Agreement, as long as each party

                                       2
<PAGE>

protects the Proprietary Information of the other, neither the exposure to the
other party's Proprietary Information, nor its ownership of work products, shall
prevent either party from using ideas, concepts, expressions, know-how, skills
and experience possessed by either party prior to its association with the other
party or developed by either party during its association with the other party,
so long as the Proprietary Information of the other party is not used. In case
of breach, the disclosing party shall have the right to seek injunctive relief.

5.0  LIMITED WARRANTY

5.1 SCOPE OF WARRANTY. Corechange warrants that it owns the Licensed Materials
or has the right to grant this license authorizing the use of the Licensed
Materials. Corechange warrants that during the first ninety (90) days following
delivery of the Coreport program ("Warranty Period"), the software programs will
substantially conform to the documentation provided with the Licensed Materials,
will not include any virus, and will be free of intentionally disabling code.
Client's exclusive remedy for non-conformance shall be that Corechange will, at
no additional charge, correct or replace any material part of the software
programs that is or becomes defective, provided that Corechange receives written
notice of the defect during the Warranty Period. If Corechange is unable to
correct or replace the software, Corechange can terminate the Agreement, and
return any license fees paid for the Licensed Materials, with no additional
liability by Corechange to Client. After the Warranty Period, such services will
only be available through continued enrollment in Corechange Support. Corechange
specifically waives responsibility for any third party product or service that
may be used in conjunction with the Licensed Materials.

5.2 ACKNOWLEDGMENTS. Unless otherwise set forth in an addendum to this
Agreement, Client acknowledges that it shall be solely responsible for (i)
providing the proper operating environment for the Licensed Materials; (ii)
installing the Licensed Materials; (iii) training end users; (iv) establishing
proper back-up procedures; (v) portal layout and look-and-feeling planning; and
(vi) user, role, content (internal and external) definition and gathering.

5.3 EXCEPTIONS. The obligations of Corechange under Section 4.1 shall not apply
to the extent Client: (i) modified the Licensed Materials, (ii) did not follow
the instructions that Corechange provided, (iii) used the Licensed Materials in
an unauthorized manner in combination with other non-Corechange products and the
claims resulted from that combination, or (iv) is not currently enrolled in
Corechange Support.

5.4 DISCLAIMER. EXCEPT FOR THE EXPRESS WARRANTIES IN SECTION 5, CORECHANGE
DISCLAIMS ALL OTHER WARRANTIES AND/OR REPRESENTATIONS, EXPRESS OR IMPLIED,
WRITTEN OR VERBAL, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF
MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE.

6.0  CORECHANGE SUPPORT

6.1 CORECHANGE SUPPORT - OVERVIEW. The services that Corechange provides Client
under Corechange Support are an important part of our business relationship.
Under Corechange Support, Corechange Corechange will offer technical telephone
support services, error corrections, and access to maintenance releases of the
Licensed Materials or terms set our in Corechange's Support Schedule. New
versions of the Licensed Materials may be made available on a discounted basis
through Corechange Support. Corechange may also develop and market new products
containing new functionality, which may include portions of previously licensed
products. These new products may not be made available through Corechange
Support.

6.2 CORECHANGE SUPPORT - ADJUSTMENTS. Corechange may adjust the annual fee (or
any portion thereof) during the enrollment period to reflect usage upgrades that
may occir during the enrollment period or to reflect increased costs of
providing Corechange Support. No refunds or credits will be given for Client's
early termination of Corechange Support.

6.3 CORECHANGE SUPPORT - REINSTATEMENT. If at any time after enrollment,
Corechange Support is terminated, Client may elect to reinstate in the program
by paying the then current annual fee for Corechange Support plus a
reinstatement fee based on the difference between the license fee initially paid
for the Licensed Materials and the prevailing license fee at the time of
reinstatement, and the cost for Support during the period when Support was
terminated.

7.0  PAYMENT

Payment of all fees specified in an invoice and not the subject of a good faith
dispute is payable upon receipt. Client acknowledges that the Licensed Materials
have been delivered to Client pursuant to the terms of this Agreement, and
Client expressly accepts delivery of such license, and agrees to be bound by the
payment terms of this contract. Invoices for Corechange Support will be issued
up to ninety (90) days prior to the renewal date. Under certain licensing
options, additional license fees may come due as a result of changes to usage,
the operating environment or system configuration. Corechange will issue an
invoice upon (i) receipt of Client's written notice specifying this
change/upgrade. Client also agrees to pay all amounts equal to any applicable
taxes (e.g. sales, use, personal property, etc.) resulting from any transaction
under this Agreement, not including any taxes based on Corechange's net income.
Invoices remaining unpaid for thirty (30) days following the date payment is due
shall accrue interest at the rate of one and one-half percent (1.5%) per month
(or such lesser amount if required by law) on any unpaid amount. Client shall
pay Corechange the fees indicated on the front page of this Agreement. Client
shall reimburse Corechange for reasonable travel and other expenses incurred as
a result of this Agreement. In

                                       3
<PAGE>

addition to the fees set forth in this Section, Client shall pay or reimburse
Corechange for all federal, state, local or other taxes (exclusive of income,
business privilege, or similar taxes), including but not limited to, sales, use,
lease or similar assessments, based on charges for the Deliverables rendered
hereunder but not taxes based on Corechange's net income or employment taxes.
Notwithstanding the foregoing, in the event Client cancels or unilaterally
reschedules the commencement date for the Services within seven (7) calendar
days prior to the agreed upon commencement date, Client shall be liable to pay
Corechange, as liquidated damages, a sum equal to twenty-five (25%) of the
contracted value of the Services.

8.0  LIMITATION OF LIABILITY

Except to the extent agreed otherwise, Client is responsible for the proper
installation and operation of the software programs including, without
limitation, confirming the proper configuration of its computer system(s). In
the event a problem arises with the Licensed Materials, Client agrees that
Corechange is only liable for monetary damages in the amount of the proven
direct actual damage. Corechange's aggregate liability to Client for all claims
shall not exceed the amount of license fees that Corechange has received from
Client for the Licensed Materials hereunder.

EXCEPT FOR CORECHANGE'S INDEMNIFICATION OBLIGATIONS OR A BREACH OF SECTION 1.3
OR 4, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER FOR THIRD PARTY
CLAIMS, OR FOR LOSS OF OR DAMAGE TO RECORDS OR DATA, OR ANY CONSEQUENTIAL,
PUNITIVE, SPECIAL AND OTHER INDIRECT DAMAGES (INCLUDING LOSS OF PROFIT),
REGARDLESS OF THE NATURE OF THE CLAIM EVEN IF INFORMED OF THE POSSIBILITY OF
SUCH DAMAGE OR LOSS.

9.0  TERMINATION

Either party may terminate in event of a material breach that remains uncured
after thirty (30) days from receipt of written notice, or ten (10) days in case
of breach of Section 1.3 or 4. Upon termination of any license set forth herein,
whether by expiration of term or by cause, Client agrees to immediately delete
all copies of the software programs that are installed on its computer systems
and return to Corechange all documentation and tangible embodiments of the
Licensed Materials, together with a written statement certifying completion of
these obligations. The provisions of Sections 1.2, 4, 5.4, and 8-11, shall
survive any termination, as shall any other section to the extant it survives by
its own terms.

10.0  INDEMNIFICATION

If a claim or action is brought against Client or its successors by a third
party arising from (1) injury to persons or property as a result of Corechange's
negligence, or (2) a claim that the Licensed Materials or Client's use or
possession of the Licensed Materials infringes a patent, copyright, trade
secret, or other intellectual property right, Corechange shall defend such claim
or action at its expense and shall pay all costs, attorney's fees, damages,
settlements and other amounts awarded or agreed to in connection with any such
claim or action, provided that Client provides (x) prompt written notice of the
claim, (y) all reasonable assistance, and (z) control of the claim to
Corechange. Corechange shall have no obligation to indemnify if the claim arises
from (i) the use of the Licensed Materials with other products not provided by
Corechange; or (ii) any unauthorized uses of or modifications to the Licensed
Materials. If Client is enjoined, precluded, or advised by Corechange to refrain
from using the Licensed Materials because of any such infringement or any
infringement claim or allegation, Corechange shall, and at Corechange's expense
and option: (a) procure for Client the right to continue using the Licensed
Materials; (b) replace or modify the Licensed Materials so that they becomes
non-infringing without materially and adversely affecting the performance of the
Licensed Materials or significantly lessening the utility of the Licensed
Materials to Client; or (c) if either of the above two options are not available
on commercially reasonable terms, accept return of the Licensed Materials at
Corechange's expense and refund that portion of the license fees based on a
three (3) year straight-line amortization. This provision states the sole and
exclusive liability of Corechange for infringement or breach of third party
rights.

11.0 MISCELLANEOUS

If any one or more of the provisions contained in this Agreement shall be held
to be invalid or unenforceable in any respect, such invalidity or
unenforceability shall not affect the other provisions of this Agreement. If
either party should waive a breach of any provisions of this Agreement, it shall
not thereby be deemed to have waived any preceding or succeeding breach of the
same or any other provisions herein. This Agreement shall be governed by and
construed in accordance with the laws of the Commonwealth of Massachusetts,
without regard to its choice of law provisions. The parties irrevocably consent
to the exclusive jurisdiction and venue of the state and federal courts in
Illinois. Corechange shall not be entitled to use Client's name or the name of
any subsidiary, parent or affiliated entity of Client's or any trade name,
trademark or service mark belonging to the entities described above in printed
brochures, press releases, or in any form of advertising for any product,
service or technology without the prior written consent of a Senior Vice
President of Client's. A copy of any notice of breach of the terms of the
Agreement shall be forwarded to: ABN AMRO North America, Inc., Attention:
Legal Department, 135 South LaSalle Street, Chicago, IL 60674.

12.0 INSURANCE

For one year after the date of execution, Corechange agrees to maintain
comprehensive general liability and property damage insurance coverage for
bodily injuries to persons and damage to physical property with limits of at
least $1,000,000 for bodily injury to persons and $1,000,000 for damage to
physical property.

                                       4
<PAGE>

                                  ATTACHMENT A

This Attachment A is incorporated in its entirety as part of this Coreport
License and Services Agreement QuickStart Package between Corechange and Client.

Scheduled Services / Project Plan:

    -    Project Review - Establish scope, content, deliverables and
         expectations. Asses requirements, resources and rollout plan. Review of
         project plan and timeframes.

    -    Software Installation - Basic configuration.

    -    (50) User information load/import.

    -    Coreport organizational structuring, role layout and assistance.

    -    Custom portal functions, creation and configuration.

    -    Test and quality assurance.

    -    Other related services, time permitting, based on client preferences.

    -    Autonomy configuration (for Autonomy Knowledge Management as listed on
         page 1)

    -    Presentation and demonstration of the portal soltuion.

                                       5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00011-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00011-of-00352.parquet"}]]